APA (7th ed.) Citation

Y, W., W, Z., Y, J., C, H., X, F., S, D., & B, Z. (2026). MO-IPS suppresses acute myeloid leukemia through metabolic reprogramming and synergizes with anti-PD-1 immunotherapy. Functional & integrative genomics, 26(1), . https://doi.org/10.1007/s10142-026-01943-8

Chicago Style (17th ed.) Citation

Y, Wang, Zhao W, Jin Y, Hu C, Fang X, Dong S, and Zhang B. "MO-IPS Suppresses Acute Myeloid Leukemia Through Metabolic Reprogramming and Synergizes with Anti-PD-1 Immunotherapy." Functional & Integrative Genomics 26, no. 1 (2026). https://doi.org/10.1007/s10142-026-01943-8.

MLA (9th ed.) Citation

Y, Wang, et al. "MO-IPS Suppresses Acute Myeloid Leukemia Through Metabolic Reprogramming and Synergizes with Anti-PD-1 Immunotherapy." Functional & Integrative Genomics, vol. 26, no. 1, 2026, https://doi.org/10.1007/s10142-026-01943-8.